Anti-HER2 CAR-T cells
Anti-HER2 CAR-T
Unknown mab active
Quick answer
Anti-HER2 CAR-T cells for HER2-positive Advanced Malignant Solid Tumors is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- HER2-positive Advanced Malignant Solid Tumors
- Phase
- Unknown
- Modality
- mab
- Status
- active